HPLC-detected albuminuria predicts mortality

Journal of the American Society of Nephrology

Volumn 18, Issue 12, 2007, Pages 3171-3176

  Magliano, Dianna J ^a,b   Polkinghorne, Kevan R ^c   Barr, Elizabeth L M ^a   Su, Qing ^a   Chadban, Steven J ^d   Zimmet, Paul Z ^a,b   Shaw, Jonathan E ^a,b   Atkins, Robert C ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ADULT; ALBUMINURIA; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNONEPHELOMETRY; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHELOMETRY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK FACTOR; URINALYSIS;

EID: 36849065889     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007030359     Document Type: Article

References (23)

1. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356-360, 1984
2. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ: Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med 1: 17-19, 1984
3. Weis U, Turner B, Gibney J, Watts GF, Burke V, Shaw KM, Cummings MH: Long-term predictors of coronary artery disease and mortality in type 1 diabetes. QJM 94: 623-630, 2001
4. Schmitz A, Vaeth M: Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 5: 126-134, 1988
5. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 41: 731-735, 1992
6. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300: 297-300, 1990
7. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, Van Gilst WH, De Zeeuw D, De Jong PE; Prevend Study Group: Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 249: 519-526, 2001
8. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 1777-1782, 2002
9. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS: Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 19: 1992-1997, 1999
10. Comper WD, Osicka TM, Jerums G: High prevalence of immunounreactive intact albumin in urine of diabetic patients. Am J Kidney Dis 41: 336-342, 2003
11. Osicka TM, Houlihan CA, Chan JG, Jerums G, Comper WD: Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage. Diabetes 49: 1579-1584, 2000
12. Comper WD, Jerums G, Osicka TM: Differences in urinary albumin detected by four immunoassays and high-performance liquid chromatography. Clin Biochem 37: 105-111, 2004
13. Osicka TM, Comper WD: Characterization of immunochemically nonreactive urinary albumin. Clin Chem 50: 2286-2291, 2004
14. Brinkman JW, Bakker SJ, Gansevoort RT, Hillege HL, Kema IP, Gans RO, de Jong PE, de Zeeuw D: Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC. Kidney Int Suppl 92: S69-S75, 2004
15. Polkinghorne KR, Su Q, Chadban SJ, Shaw JE, Zimmet PZ, Atkins RC: Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: Immunonephelometry compared with high-performance liquid chromatography. Am J Kidney Dis 47: 604-613, 2006
16. McQueen MJ, Gerstein HC, Pogue J, Mann JF, Yusuf S: Reevaluation by high-performance liquid chromatography: Clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study. Am J Kidney Dis 48: 889-896, 2006
17. Comper WD, Osicka TM, Clark M, MacIsaac RJ, Jerums G. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int 65: 1850-1855, 2004
18. Sviridov D, Meilinger B, Drake SK, Hoehn GT, Hortin GL: Coelution of other proteins with albumin during size-exclusion HPLC: Implications for analysis of urinary albumin. Clin Chem 52: 389-397, 2006
19. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M, Jolley D, McCarty DJ; Australian Diabetes, Obesity and Lifestyle Study (AusDiab): The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)-methods and response rates. Diabetes Res Clin Pract 57: 119-129, 2002
20. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE, Parving HH, Steffes MW; American Diabetes Association: Nephropathy in diabetes. Diabetes Care 27(Suppl 1): S79-S83, 2004
21. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G: Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-2100, 2005
22. Mathew TH: Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: A position statement. Med J Aust 183: 138-141, 2005
23. Youden WJ: An index for rating diagnostic tests. Cancer 3: 32-35, 1950